A frameshift mutation is a type of mutation involving the insertion or deletion of a nucleotide in which the number of deleted base pairs is not divisible by three. "Divisible by three" is important because the cell reads a gene in groups of three bases. Each group of three bases corresponds to one of 20 different amino acids used to build a protein. If a mutation disrupts this reading frame, then the entire DNA sequence following the mutation will be read incorrectly.
To play the media you will need to either update your browser to a recent version or update your Flash plugin
A frameshift mutation is a particular type of mutation that involves either insertion or deletion of extra bases of DNA. Now, what's important here is the number three. The number of bases that are either added or subtracted can't be divisible by three. And that's important because the cell reads a gene in groups of three bases. Every group of three bases corresponds to one of the 20 different amino acids that are used by your body to make proteins. And keep in mind your body has a lot of proteins; everything from the material that makes up your skin, to the material that makes up your hair, to the digestive juices that help you digest that yummy lunch you just had. If a mutation disrupts one of those reading frames, so that the wrong amino acid is put in place, then the entire DNA sequence following the mutation will be disrupted or read incorrectly. Very often, what we see is a premature termination. Instead of the encoded protein being of a certain particular size, it'll end up being much shorter, and it won't be able to accomplish the role that's been set out for it.
Name: Elaine A. Ostrander, Ph.D.
Occupation: Chief and Senior Investigator, Cancer Genetics Branch; Head, Comparative Genetics Section
Biography: Dr. Ostrander's laboratory maps genes responsible for cancer susceptibility in canines and humans. Cancer is the number one killer of dogs. Studying the major cancers in dogs provides a valuable approach for developing a better-understanding of the development of cancer in humans. The clinical presentation, histology, and biology of many canine cancers closely parallel those of humans, so comparative studies of canine and human cancer genetics should be of significant clinical benefit to both. Dr. Ostrander's laboratory is constructing and using high-density maps of the canine genome to identify genes associated with genetic forms of lymphoma, osteosarcoma and kidney cancer.